MedTrace Logo

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry

NCT01325467 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2012-03-29

No results posted yet for this study

Summary

This will be a registry study that will enroll patients referred for an ECG treadmill test with nuclear myocardial perfusion imaging (MPI). The high frequency QRS (HFQRS) information will be recorded and analyzed automatically and simultaneous with the standard ECG signals by the HyperQ System. Results of subsequent tests performed on each patient will be collected and used to enhance the reliability of designating each patient as a CAD-negative (i.e., no significant coronary artery disease) or a CAD-positive (i.e., significant coronary artery disease).

Conditions

Sponsors & Collaborators

  • BSP Biological Signal Processing Ltd.

    lead INDUSTRY

Principal Investigators

  • Jamieson M Bourque, MD · University of Virginia Health System

  • Robert Schwartz, MD · Minneapolis Heart Institute Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01325467 on ClinicalTrials.gov